vaccine

Characteristics of Physicians Who Dismiss Families for Refusing Vaccines

The American Academy of Pediatrics discourages providers from dismissing families who refuse vaccines for their children, yet some providers continue to do so.

We show that ~1 in 5 pediatricians dismiss families who refuse vaccines, and there is significant regional variation in the practice. Dismissing families for refusing vaccines was also associated with stricter state nonmedical exemption policies. (Read the full article)




vaccine

Should I keep my child's vaccine appointments?




vaccine

Efficacy and Effectiveness of the PCV-10 and PCV-13 Vaccines Against Invasive Pneumococcal Disease

CONTEXT:

Pneumococcal conjugate vaccines (PCVs) (pneumococcal 13-valent conjugate vaccine [PCV-13] and pneumococcal 10-valent conjugate vaccine [PCV-10]) are available for prevention of pneumococcal infections in children.

OBJECTIVE:

To determine the vaccine effectiveness (VE) of PCV-13 and PCV-10 in preventing invasive pneumococcal disease (IPD) and acute otitis media (AOM) in children <5 years.

DATA SOURCES:

Systematic searches of Medline, Embase, Cumulative Index to Nursing and Allied Health Literature, Web of Science, and Cochrane.

STUDY SELECTION:

Eligible studies examined the direct effectiveness and/or efficacy of PCV-10 and PCV-13 in reducing the incidence of disease in healthy children <5 years.

DATA EXTRACTION:

Two reviewers independently conducted data extraction and methodologic quality assessment.

RESULTS:

Significant effectiveness against vaccine-type IPD in children ≤5 years was reported for ≥1 dose of PCV-13 in the 3 + 1 (86%–96%) and 2 + 1 schedule (67.2%–86%) and for PCV-10 for the 3 + 1 (72.8%–100%) and 2 + 1 schedules (92%–97%). In children <12 months of age, PCV-13 VE against serotype 19A post–primary series was significant for the 3 + 1 but not the 2 + 1 schedule. PCV-10 crossprotection against 19A was significant in children ≤5 years with ≥1 dose (82.2% and 71%). Neither PCVs were found effective against serotype 3. PCV-13 was effective against AOM (86%; 95% confidence interval [CI]: 61 to 94). PCV-10 was effective against clinically defined (26.9%; 95% CI: 5.9 to 43.3) and bacteriologically confirmed AOM (43.3%; 95% CI: 1.7 to 67.3).

LIMITATIONS:

Because of the large heterogeneity in studies, a meta-analysis for pooled estimates was not done.

CONCLUSIONS:

Both PCVs afford protection against pneumococcal infections, with PCV-10 protecting against 19A IPD, but this VE has not been verified in the youngest age groups.




vaccine

Vancouver archbishop donates to coronavirus vaccine research

Denver Newsroom, Apr 28, 2020 / 05:17 pm (CNA).- Archbishop Michael Miller of Vancouver has announced that he is donating to the University of British Columbia’s research toward a COVID-19 vaccine.

“May the search for COVID-19 solutions also be a moment of solidarity, of collaboration, and of growing together as a visible sign to the world of the healing and reconciliation so needed right now,” Archbishop Miller said April 27 as reported by the B.C. Catholic.

Ryan Thomas, a special advisor to the archdiocese, told CNA that Archbishop Miller wanted to express, through his donation, the Catholic Church’s support for science and medicine that contribute to the common good.

“The Church— as Pope Francis has said from the beginning of his pontificate— is called to go out, we're called to engage, not called to retreat,” Thomas told CNA.

“From a scientific standpoint, that means identifying the research that is worthy of our investment, that meets the high standards that we have to protect life,” he said.

Thomas declined to specify the amount of the donation, but said that it was in the thousands of dollars.

The global effort to develop a COVID-19 vaccine includes at least 50 other research teams, the university says, many of which in the U.S. and Canada have received government funding and are being conducted by large pharmaceutical companies.

Pro-life leaders have warned in recent months that among the many COVID-19 vaccines currently in development worldwide, in some cases researchers are using old cell lines derived from the cells of aborted babies.

It was important to Archbishop Miller, Thomas said, that the Church be seen to be promoting research into a vaccine that Catholics can support in good conscience.

A group of Evangelical Christians and Catholics in Vancouver began to rally around the idea of supporting a vaccine that corresponded to Christian ethical standards, and eventually presented the idea of supporting UBC’s research to Archbishop Miller.

Thomas said Miller made sure to inquire about whether UBC’s vaccine research makes use of aborted fetal cells, which it does not.

Dr. Wilf Jefferies, the project’s lead researcher, told CNA via email that his research team is currently in the process of validating the potency of vaccine candidates in preclinical trials, in order to assess their potential toxicity before trying them in human subjects.

The UBC lab is using immune-boosting components called adjuvants in its vaccine candidate, with the hopes of reducing the dosage of vaccine required for complete protection against the disease. In addition, Jefferies hopes that UBC’s vaccine will continue to provide protection against COVID-19 even if the virus mutates over time.

“I am heartened by the unity and kindness that is being demonstrated during this pandemic,” Jefferies told CNA.

“I think the response by the archdiocese is an affirmative and practical way to address the critical need in our society to develop a vaccine...I am sincerely humbled by the support we have received from the archdiocese and from other groups and individuals.”

So far, Jefferies’ lab has received grants from the government-funded Michael Smith Health Research Foundation and the Sullivan Urology Foundation affiliated with the University of British Columbia, as well as a number of private donations.

There are at least 1,000 clinical trials currently taking place around the world to test potential COVID-19 vaccines.

A group of pro-life leaders in a letter to the Trump administration earlier this month reiterated that development of a COVID-19 vaccine should avoid unethical links to abortion.

“No American should be forced to choose between being vaccinated against this potentially deadly virus and violating his or her conscience,” reads the April 17 letter to Dr. Stephen M. Hahn, commissioner of the U.S. Food and Drug Administration.

“Fortunately, there is no need to use ethically problematic cell lines to produce a COVID vaccine, or any vaccine, as other cell lines or processes that do not involve cells from abortions are available and are regularly being used to produce other vaccines,” it continued.

The letter’s signers include Archbishop Joseph Naumann of Kansas City in Kansas, chair of the U.S. Conference of Catholic Bishops’ Committee on Pro-Life Activities; the heads of three other bishops’ conference committees; and leaders of many other Catholic and non-Catholic groups.

The Pontifical Academy for Life has noted that Catholics have an obligation to use ethically-sourced vaccines when available, and have an obligation to speak up and request the development of new cell lines that are not derived from aborted fetuses.

The 2008 Vatican document Dignitatis personae strongly criticized aborted fetal tissue research. However, as regards common vaccines, such as those for chicken pox and measles, mumps, and rubella (MMR), that may be derived from cell lines of aborted babies, the Vatican said they could be used by parents for “grave reasons” such as danger to their children’s health.

In a 2017 document on vaccines, the academy noted a “moral obligation to guarantee the vaccination coverage necessary for the safety of others… especially the safety of more vulnerable subjects such as pregnant women and those affected by immunodeficiency who cannot be vaccinated against these diseases.”

 




vaccine

1 in 4 Americans Would Refuse COVID-19 Vaccine from Government

Source: www.thegatewaypundit.com - Friday, May 08, 2020
One in Four Americans would refuse a COVID-19 vaccine according to a new ABC News/Ipsos poll. The news comes as Americans trust in the medical community continues to plunge thanks to overblown predictions on the extent of the coronavirus pandemic, fake news reporting and the continued attacks on hydroxychloroquine treatments that are showing great success. HUGE UPDATE: Dr. Fauci and Dr. Birx Used Imperial College Model — NOW CONFIRMED AS A COMPLETE FRAUD — To Persuade President Trump to Lock Down Entire US Economy! After losing your business and livelihood due to faulty models and predictions why would you trust the government with a COVID-19 vaccine? Via ABC Action News : Americans, by a large 30-point margin, are resistant to re-opening the country now, believing the risk to human life of opening the country outweighs the economic toll of remaining under restrictive lockdowns — a concern that starkly divides along partisan lines, according to a new ABC News/Ipsos released Friday. In the new poll, conducted by Ipsos in partnership with ABC News using Ipsos’ Knowledge Panel, nearly two-thirds of Americans said they more closely align with the view that opening the county now is not advantageous since it will result in a higher death toll, while slightly more than one-third agree with the belief that an immediate reopening is beneficial to minimize the negative impact on the economy. But those attitudes show deep partisan divisio




vaccine

Fin24.com | WATCH: Pfizer begins coronavirus vaccine tests on humans

Pfizer and BioNTech said Tuesday they have begun delivering doses of their experimental coronavirus vaccines for initial human testing in the United States.




vaccine

DPH Reminds Delawareans to Get Their Flu Vaccines as it Announces First Flu-Related Deaths of 2019-2020 Season

DOVER – The Division of Public Health (DPH) is reminding Delawareans to protect themselves and those around them this influenza season by getting vaccinated as DPH announces the first two flu-related deaths of the 2019-2020 flu season. A 68-year-old woman infected with influenza A, and a 65-year-old man infected with influenza B, passed away this […]



  • Delaware Health and Social Services
  • Division of Public Health
  • 2019-2020 flu season
  • DE Division of Public Health
  • Delaware Division of Public Health
  • DPH
  • flu
  • flu deaths
  • flu vaccine

vaccine

COVID-19 outbreak: Pune’s Serum Institute all set to make under-trial Coronavirus vaccine

Once the clinical trials are over and successful, SII will release its vaccine. If the clinical trials by Oxford are not successful then the loss will be of SII. Some limited clinical trials will be done by SII also.




vaccine

Polio vaccine could beat Coronavirus: Dr Robert Gallo, HIV co-discoverer

Dr Gallo and Dr Chumakov briefly talk about research showing non-specific protection from vaccines such as BCG, measles and other live attenuated (weakened) vaccines.




vaccine

Coronavirus Vaccine News Today: WHO says infecting healthy volunteers with COVID-19 may speed up vaccine search

Such studies, which pose significant potential dangers to subjects, may be considered in dire situations and with certain disclosures and protections, a working group of the United Nations health agency said in a report posted Wednesday on its website.




vaccine

Coronavirus vaccine development: What’s happening in the US, China, Russia, UK, Germany, France for COVID-19 cure

The stakes in finding a vaccine against the coronavirus couldn’t be higher. In just a few months the disease has claimed more than a quarter of a million lives and shattered economies worldwide.




vaccine

Race for corona vaccine hots up; US, China enter human-trials stage

At least two candidates have already entered the clinical evaluation stage, according to the World Health Organization (WHO).




vaccine

Hyderabad biotech firm working on intranasal vaccine against Covid-19 with US company, varsity

The institute has a high-level bio-safety facility designated Biosafety Level 3 Agriculture with the ability to safely handle and study pathogens like highly pathogenic influenza viruses and the novel coronavirus.




vaccine

Covid-19 vaccine quest: Containment and mitigation might be the only strategy till vaccine comes

Efforts are underway to develop a vaccine for Coronavirus on an urgent basis, but it’s a long-drawn process




vaccine

ICMR teams up with Bharat Biotech to develop COVID-19 vaccine

The death toll due to COVID-19 rose to 1,981 and the number of cases climbed to 59,662 in the country on Saturday, the Health Ministry said.




vaccine

~$CPIL$368465$title$textbox$USDA Grants Zoetis Vanguard crLyme Vaccine for Dogs a 15-month DOI Claim$/CPIL$~




vaccine

~$CPIL$368467$title$textbox$Immunovaccine Announces Achievement of Milestones in Collaboration with Zoetis to Develop Veterinary Vaccines$/CPIL$~




vaccine

~$CPIL$372154$title$textbox$Zoetis PRRS Vaccine Gains Approval in Europe$/CPIL$~




vaccine

~$CPIL$384904$title$textbox$Vanguard Rapid Resp: First Vaccines to Provide 1-Year Immunity from 3 CIRDs$/CPIL$~




vaccine

~$CPIL$384903$title$textbox$Zoetis launches new vaccine for porcine reproductive and respiratory syndrome$/CPIL$~




vaccine

Zoetis to Acquire PHARMAQ, the Global Leader in Vaccines and Innovation for Health Products in Aquaculture




vaccine

Zoetis Completes Purchase of PHARMAQ, the Global Leader in Vaccines and Innovation for Health Products in Aquaculture




vaccine

World leaders pledge €7.4bn to research Covid-19 vaccine

EU-hosted talks tout cooperation but is not addressed by India, Russia or US

World leaders, with the notable exception of Donald Trump, stumped up nearly €7.4bn (£6.5bn) to research Covid-19 vaccines and therapies at a virtual event convened by the EU, pledging the money will also be used to distribute any vaccine to poor countries on time and equitably.

But in a sign of the fractured state of global health diplomacy, the event was not addressed by India, Russia or the US. After a weekend of persuasion, China was represented by its ambassador to the EU.

UK data from the Office for National Statistics has revealed that men are almost twice as likely to die from the disease as women. The trend was first seen in China, where one analysis found a fatality rate of 2.8% in men compared with 1.7% in women. Since then, the pattern has been mirrored in France, Germany, Iran, South Korea and Italy, where men have accounted for 71% of deaths.

UK data from the Office for National Statistics has revealed that men are almost twice as likely to die from the disease as women. The trend was first seen in China, where one analysis found a fatality rate of 2.8% in men compared with 1.7% in women. Since then, the pattern has been mirrored in France, Germany, Iran, South Korea and Italy, where men have accounted for 71% of deaths.

Continue reading...





vaccine

Vaccine works on monkeys

A CORONAVIRUS vaccine developed in China has been proven effective on monkeys. PiCoVacc, a vaccine made by Beijing-based Sinovac Biotech, used a typical method to prevent the virus from infecting life




vaccine

COVID-19: Primate Ayodele predicts when vaccine will be discovered

The founder of Inri Evangelical Spiritual Church, Primate Elijah Ayodele, has predicted that the vaccine for COVID-19 will be discovered in July this year. Scientists around the world are yet to make a breakthrough with regards to a cure for the virus, since it broke out earlier this year in Wuhan, China. In the last […]

COVID-19: Primate Ayodele predicts when vaccine will be discovered




vaccine

Europe Launches Massive Campaign to Fund Coronavirus Vaccine

On Monday, European Commission President Ursula von der Leyen and a number of world leaders are launching a massive fundraising endeavor to raise money for tests, medicines and a vaccine for the coronavirus. Only one major country is missing in the effort.




vaccine

Trump says coronavirus will disappear without a vaccine but Fauci says opposite

Donald Trump has been bullish about a coronavirus vaccine – so much so that experts have had to talk him off a more aggressive...




vaccine

ICMR teams up with Bharat Biotech to develop Covid-19 vaccine - Hindustan Times

  1. ICMR teams up with Bharat Biotech to develop Covid-19 vaccine  Hindustan Times
  2. Bharat Biotech to lead monoclonal antibodies project for Covid-19 therapy  The Financial Express
  3. Bharat Biotech leads CSIR project to develop antibodies against Covid-19  Times of India
  4. Bharat Biotech to lead project on monoclonal antibodies therapy for COVID-19  The New Indian Express
  5. Indian scientists to develop medicine against COVID-19  Deccan Herald
  6. View Full coverage on Google News




vaccine

COVID-19 Deaths Before A Vaccine?

How many COVID-19 deaths will occur before a vaccine becomes available worldwide? As with many seemingly simple questions about an uncertain future, the proper answer to that important query is: “it depends”. The total worldwide number of deaths from COVID-19 before a vaccine, reported to be nearly a quarter-million at the end of April and […]

The post COVID-19 Deaths Before A Vaccine? appeared first on Inter Press Service.




vaccine

Turkey advancing toward vaccine: Technology minister

Turkish scientists have come to the animal experiment phase to develop a vaccine against the novel coronavirus, the country's technology and industry minister said on May 8. 




vaccine

Operation Warp Speed needs to waste money on vaccines

Most candidates won’t work, but it’s essential to be ready to mass-produce the one that does.




vaccine

Why I just volunteered for a COVID-19 vaccine trial

The notion of testing COVID-19 vaccines by deliberately infecting volunteers with the novel coronavirus — something that’s now on the table — isn’t necessarily crazy ...




vaccine

Rafael Nadal says Novak Djokovic will have to take vaccine if required by tour

Rafael Nadal says Novak Djokovic will need to be vaccinated to keep playing if the governing bodies of tennis make coronavirus shots obligatory once they ...




vaccine

Tuberculosis BCG vaccine gets into global Covid-19 trial

South Africa vaccinates health workers in response to the pandemic.




vaccine

Polio, Measles Outbreaks ‘Inevitable’, Say Vaccine Experts

Interruptions to vaccination programmes caused by the COVID-19 pandemic could result in new waves of measles or polio outbreaks, health experts warn. A growing number of one-off immunisation campaigns and national routine vaccine introductions are being delayed amid social distancing and other measures to curb the spread of SARS-CoV-2, leaving millions unprotected. Uptake of routine […]

The post Polio, Measles Outbreaks ‘Inevitable’, Say Vaccine Experts appeared first on Inter Press Service.




vaccine

Coronavirus vaccine: Virus mutations could hold clues for COVID-19 cure

1




vaccine

Asia should lead the way in producing a novel coronavirus vaccine -- by Matthias Helble, Susann Roth

The Asia-Pacific region has the expertise and resources to take a leadership role in not only developing a COVID-19 vaccine but distributing it to those who need it most.




vaccine

How soon will we have a coronavirus vaccine? The race against covid-19

The hope is that we will have a coronavirus vaccine in 12-18 months, but for that to happen we may have to rely on untested techniques - and that comes with its own risks.




vaccine

Pfizer to outsource some drug production, focus on coronavirus vaccine

Pfizer Inc said on Friday it is in talks to shift more of its medicine production to outside contractors as it prepares for large-scale production of an experimental vaccine to prevent COVID-19, should it prove safe and effective.




vaccine

UPDATE 1-Pfizer to outsource some drug production, focus on coronavirus vaccine

Pfizer Inc said on Friday it is in talks to shift more of its medicine production to outside contractors as it prepares for large-scale production of an experimental vaccine to prevent COVID-19, should it prove safe and effective.




vaccine

BCG vaccine being trialled as potential protection against covid-19

A long-standing hypothesis suggests the BCG vaccine also serves to generally enhance the immune system, meaning it could protect against covid-19, and trials are under way to find out




vaccine

Why it’ll still be a long time before we get a coronavirus vaccine

Trials of experimental coronavirus vaccines are already under way, but it’s still likely to be years before one is ready and vaccination may not even be possible




vaccine

BCG vaccine helps fight infections by boosting immune cell production

The BCG tuberculosis vaccine boosts the production of immune cells and this may explain how it protects newborns from dying of sepsis




vaccine

Pfizer, BioNTech race to test vaccines

Pfizer's chief scientific officer tells Reuters his company got a head start on vaccine development for the coronavirus because it had already been working for two years on the flu with its German partner, BioNTech. Fred Katayama reports.




vaccine

Prostate Cancer Vaccine May Get FDA Approval

Title: Prostate Cancer Vaccine May Get FDA Approval
Category: Health News
Created: 4/27/2010 8:10:00 AM
Last Editorial Review: 4/27/2010 12:00:00 AM




vaccine

FDA OKs Meningitis Vaccine for Infants

Title: FDA OKs Meningitis Vaccine for Infants
Category: Health News
Created: 4/27/2011 11:00:00 AM
Last Editorial Review: 4/27/2011 12:00:00 AM




vaccine

Vaccine Against Bird Flu Readied, Just in Case

Title: Vaccine Against Bird Flu Readied, Just in Case
Category: Health News
Created: 4/30/2014 2:36:00 PM
Last Editorial Review: 5/1/2014 12:00:00 AM




vaccine

HPV Vaccine Produces Early Benefits for Teen Girls: Study

Title: HPV Vaccine Produces Early Benefits for Teen Girls: Study
Category: Health News
Created: 4/27/2015 12:00:00 AM
Last Editorial Review: 4/27/2015 12:00:00 AM




vaccine

Experimental AIDS Vaccine Targets Hidden Virus

Title: Experimental AIDS Vaccine Targets Hidden Virus
Category: Health News
Created: 4/29/2015 12:00:00 AM
Last Editorial Review: 4/29/2015 12:00:00 AM